×

Radio and PodcastLive Radio & Podcasts

Discover Radio

Radio Radio by Country Radio by Genre Radio by Language Favorite Radio Radio History

Discover Podcast

Podcasts Podcast by Country Podcast by Category Podcast by Language Podcast History Subscribed Podcasts Favorite Episodes

Helpful Links

Widget About Us Contact Editorial Policy Privacy Policy Terms of Use

Mobile App

Listen Radio and Podcast Anywhere Anytime

Download our app for smooth radio and podcast listening on Android and iOS.

▶Get it onGoogle Play

Radio and PodcastLive Radio & Podcasts

Your world of live radio, podcasts and music.

F IG X in P ▶

Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Loading episode

Fetching episode details...

×

Radio and PodcastLive Radio & Podcasts

Discover Radio

Radio Radio by Country Radio by Genre Radio by Language Favorite Radio Radio History

Discover Podcast

Podcasts Podcast by Country Podcast by Category Podcast by Language Podcast History Subscribed Podcasts Favorite Episodes

Helpful Links

Widget About Us Contact Editorial Policy Privacy Policy Terms of Use

Mobile App

Listen Radio and Podcast Anywhere Anytime

Download our app for smooth radio and podcast listening on Android and iOS.

▶Get it onGoogle Play

Radio and PodcastLive Radio & Podcasts

Your world of live radio, podcasts and music.

F IG X in P ▶

Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›New FDA Approvals›161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal artwork

Science & Medicine

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal

New FDA Approvals

Jul 23, 201809:24Science & Medicine

161 – Ivosidenib for AML; Mobile Cardiac Rehabilitation System; AGN-241751 for MDD; Senseonics Implantable Glucose Sensor; Essure withdrawal - New FDA Approvals

Related Episodes

Continue listening to more episodes from New FDA Approvals.

162 - elagolix for endometriosis pain; smartphone urinalysis; magnetic device system for guiding sentinel lymph node biopsies

Jul 26, 2018 - 08:17

160 - darunavir single tablet; pain relief study; Tau modifier gets orphan drug designation; IND for CARMA platform; CAM2038 for opioid use disorder; FDA's speedy oncology review pilot; empowering nonprescription drugs

Jul 19, 2018 - 14:43

159 - First smallpox treatment; enzalutamide for nmCRPC; PCT assay expanded use; romosozumab for osteoporosis

Jul 16, 2018 - 08:32

158 - REC-994 for cerebral cavernous malformation; RD1 innovative device for wound management; FDA 510(k) clearance for device to monitor eyesight in AMD; low dose loteprednol; OBI-3424 for HCC; fluoroquinolones labeling; FDA Gene therapy guidance

Jul 12, 2018 - 14:45

157 - FDA clears adipose tissue system for surgical repair; IND application for BAY 1905254; ARISTADA® for schizophrenia; COM701, a first-in-class Immuno-oncology antibody

Jul 9, 2018 - 09:45

156 – Approval of Braftovi for melanoma; Xyrem for narcolepsy; spinal fusion system for lordosis; new device for emphysema; a wipe for sweaty armpits; Aptos c-Myc drug off the hook

Jul 2, 2018 - 11:58

155 - cannabidiol of lennoxgastault syndrome; clearance of Access hsTnI assay; FRESCA CPAP system; FDA meeting announcement for Nutrition Innovation Strategy

Jun 28, 2018 - 09:47

154 - first catheter-based systems for vascular access in hemodialysis; PCS499 in necrobiosis lipoidica; automated insulin delivery for younger patients; first implantable continuous glucose monitoring system.

Jun 25, 2018 - 08:53